Page last updated: 2024-08-21

myristic acid and Atherosclerosis

myristic acid has been researched along with Atherosclerosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Binesh, A; Devaraj Sivasitambaram, N; Halagowder, D1
Ahnström, J; Binder, CJ; Björkbacka, H; Christoffersen, C; Dahlbäck, B; Elsøe, S; Heinecke, JW; Hoofnagle, AN; Nielsen, LB; Plomgaard, P1
Braam, B; Verhaar, MC1

Reviews

1 review(s) available for myristic acid and Atherosclerosis

ArticleYear
Understanding eNOS for pharmacological modulation of endothelial function: a translational view.
    Current pharmaceutical design, 2007, Volume: 13, Issue:17

    Topics: Animals; Atherosclerosis; Cardiovascular Agents; Cardiovascular Diseases; Endothelium, Vascular; Gene Expression Regulation, Enzymologic; Guanylate Cyclase; Humans; Kidney Diseases, Cystic; Myristic Acid; Nitric Oxide; Nitric Oxide Synthase Type III; Palmitic Acid; Phosphorylation; Protein Processing, Post-Translational; Reactive Oxygen Species; Receptors, Cytoplasmic and Nuclear; Risk Factors; Signal Transduction; Soluble Guanylyl Cyclase

2007

Other Studies

2 other study(ies) available for myristic acid and Atherosclerosis

ArticleYear
Monocytes treated with ciprofloxacin and oxyLDL express myristate, priming atherosclerosis.
    Journal of biochemical and molecular toxicology, 2020, Volume: 34, Issue:3

    Topics: Atherosclerosis; Ciprofloxacin; Gene Expression Regulation; Humans; Lipoproteins, LDL; Monocytes; Myristic Acid; THP-1 Cells

2020
Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL.
    Atherosclerosis, 2012, Volume: 221, Issue:1

    Topics: Amidines; Animals; Antioxidants; Apolipoproteins; Apolipoproteins M; Atherosclerosis; Binding Sites; Cholesterol, Dietary; Disease Models, Animal; Humans; Lipocalins; Lipoproteins, HDL; Lipoproteins, LDL; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Myristic Acid; Oxidants; Oxidation-Reduction; Phospholipids; Receptors, LDL; Recombinant Proteins; Thiobarbituric Acid Reactive Substances; Time Factors

2012